Phantom Limb: Clinical Trials

6 trials for Phantom Limb, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 withdrawn. 6 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Recruiting 1, Withdrawn 1
Phase 32Completed 1, Recruiting 1

Follow Phantom Limb: new trials by email Literature Review of Phantom Limb trials Research Report on Phantom Limb

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
IM ketamine in dose finding and then continuation - Phantom Limb Syndrome With Pain
Phase 2 / Phase 3RecruitingThe Ketamine Research Foundation302026-01-152026-03-18
A Trial of Lidocaine Patch for Lower Limb Amputation Pain
Lidocaine, Sham - Phantom Limb Pain (PLP), Primary/Secondary Scar Hyperalgesia
Phase 2WithdrawnBrugmann University Hospital2016-05-132018-01-23
Valproic Acid for the Prevention of Post-Amputation Pain
Valproic Acid, Cherry Syrup - Pain, Phantom, Pain, Neuropathic
Phase 2CompletedDuke University1282013-12-012018-12-19
Nabilone for the Treatment of Phantom Limb Pain
Nabilone - Phantom Limb Pain, Neuropathic Pain
Phase 2CompletedUniversity of Manitoba502009-01-012011-04-29
Optimized Perioperative Analgesia Reduces the Prevalence and the Intensity of Phantom Pain in Lower Limb Amputation
perioperative epidural catheter - Phantom Limb Pain
Phase 2 / Phase 3CompletedUniversity of Patras602003-12-012011-11-07
Efficacy of Opioids and Mexiletine for the Treatment of Postamputation Pain
morphine and mexiletine - Amputation, Chronic Pain
Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)601997-07-012006-10-03

Narrower conditions

Pain (3)  ·  Neuralgia (2)  ·  Agnosia (1)  ·  Chronic Pain (1)

Broader conditions

Nervous System Diseases (6)  ·  Neurobehavioral Manifestations (6)  ·  Neurologic Manifestations (6)  ·  Pain, Postoperative (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Perceptual Disorders (6)  ·  Postoperative Complications (6)  ·  Signs and Symptoms (6)  ·  Pain (3)  ·  Neuromuscular Diseases (2)  ·  Peripheral Nervous System Diseases (2)

Interventions

Lidocaine (1)  ·  Mexiletine (1)  ·  Morphine (1)  ·  Valproic Acid (1)  ·  nabilone (1)  ·  salicylhydroxamic acid (1)

Sponsors

Brugmann University Hospital (1)  ·  Duke University (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  The Ketamine Research Foundation (1)  ·  University of Manitoba (1)  ·  University of Patras (1)

Countries

United States (3)  ·  Belgium (1)  ·  Canada (1)  ·  Greece (1)

Top investigators

Diamanto N. Aretha, MD (1)  ·  Georgia Monantera, MD (1)  ·  Ioannis Tsolakis, MD Professor (1)  ·  Kriton S Filos, MD Professor (1)  ·  Menelaos Karanikolas, MD, MPH (1)  ·  Ryan Q Skrabek, MD, FRCPC (1)  ·  Samar Hatem, MD (1)  ·  Simone Brienza, MD (1)  ·  Srinivasa N Raja, M.D. (1)  ·  Thomas E Buchheit, MD (1)

Results publications

PMID 18648238, PMID 21368651